ArticleCancer biology & therapy2022

Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma.

Andrew Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.